ArticleNature cancer2025

A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.

Eric M Thompson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.